27572131|t|Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
27572131|a|Glucagon family of peptide hormones is a group of structurally related brain-gut peptides that exert their pleiotropic actions through interactions with unique members of class B1 G protein-coupled receptors (GPCRs). They are key regulators of hormonal homeostasis and are important drug targets for metabolic disorders such as type-2 diabetes mellitus (T2DM), obesity, and dysregulations of the nervous systems such as migraine, anxiety, depression, neurodegeneration, psychiatric disorders, and cardiovascular diseases. The current review aims to provide a detailed overview of the current understanding of the pharmacological actions and therapeutic advances of three members within this family including glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), and glucagon.
27572131	0	23	Pharmacological Actions	T038	UMLS:C0007992
27572131	27	50	Glucagon-Like Peptide-1	T103	UMLS:C0061355
27572131	52	82	Gastric Inhibitory Polypeptide	T103	UMLS:C0017132
27572131	88	96	Glucagon	T103	UMLS:C0017687
27572131	97	112	Glucagon family	T103	UMLS:C0017687
27572131	116	132	peptide hormones	T103	UMLS:C0597192
27572131	168	186	brain-gut peptides	T103	UMLS:C0030956
27572131	204	223	pleiotropic actions	T038	UMLS:C2936488
27572131	250	276	unique members of class B1	T170	UMLS:C0008902
27572131	277	304	G protein-coupled receptors	T103	UMLS:C0682972
27572131	306	311	GPCRs	T103	UMLS:C0682972
27572131	350	361	homeostasis	T038	UMLS:C0019868
27572131	380	392	drug targets	T074	UMLS:C0085104
27572131	397	416	metabolic disorders	T038	UMLS:C0025517
27572131	425	449	type-2 diabetes mellitus	T038	UMLS:C0011860
27572131	451	455	T2DM	T038	UMLS:C0011860
27572131	458	465	obesity	T038	UMLS:C0028754
27572131	471	508	dysregulations of the nervous systems	T038	UMLS:C0027765
27572131	517	525	migraine	T038	UMLS:C0149931
27572131	527	534	anxiety	T038	UMLS:C0003469
27572131	536	546	depression	T038	UMLS:C0011570
27572131	548	565	neurodegeneration	T038	UMLS:C0027746
27572131	567	588	psychiatric disorders	T038	UMLS:C0004936
27572131	594	617	cardiovascular diseases	T038	UMLS:C0007222
27572131	710	733	pharmacological actions	T038	UMLS:C0007992
27572131	738	758	therapeutic advances	T058	UMLS:C0087111
27572131	805	828	glucagon-like peptide-1	T103	UMLS:C0061355
27572131	830	835	GLP-1	T103	UMLS:C0061355
27572131	838	868	gastric inhibitory polypeptide	T103	UMLS:C0017132
27572131	870	873	GIP	T103	UMLS:C0017132
27572131	880	888	glucagon	T103	UMLS:C0017687